National Marrow Donor Program Executive and Leadership Team

Amy Ronneberg, the Chief Executive Officer at National Marrow Donor Program, directs the organization's overarching strategy and operational execution. This leadership role involves guiding the company's evolution and ensuring alignment with its mission of advancing cellular therapy. Ronneberg oversees the integration of new technologies and medical advancements to enhance patient outcomes and donor engagement. The Chief Executive Officer's responsibilities include fostering strategic partnerships and driving growth initiatives across all organizational functions. By championing innovation, Amy Ronneberg ensures the organization remains at the forefront of life-saving treatments and donor registries. This executive's focus is on expanding the reach and impact of the National Marrow Donor Program globally, securing its position as a leader in the field.

Katherine Heyerdahl, the Chief Financial Officer at National Marrow Donor Program, manages all financial operations and strategic fiscal planning. This critical role involves overseeing budgeting, financial reporting, and resource allocation to support the organization's mission. Heyerdahl ensures financial stability and compliance, driving efficiency across departments. The Chief Financial Officer's responsibilities include developing financial models to forecast future needs and identify investment opportunities in research and development. By optimizing financial performance, Katherine Heyerdahl directly contributes to the organization's capacity to expand its life-saving services. This executive's oversight extends to managing financial risks and ensuring sustainable growth for the National Marrow Donor Program.

Erika Brandt, the President at National Marrow Donor Program, drives strategic initiatives and operational excellence across key organizational functions. This leadership position involves overseeing the implementation of programs designed to expand donor registries and improve patient access to life-saving treatments. Brandt focuses on fostering collaboration among internal teams and external partners to advance the organization's mission. The President's responsibilities include ensuring that all operational activities align with the strategic goals of the National Marrow Donor Program. By leading cross-functional efforts, Erika Brandt contributes significantly to the organization's capacity to facilitate life-saving transplants. This executive's dedication is central to achieving greater impact in the field of cellular therapy.

Chris Arevalos-Jimenez, the President & Co-Founder at National Marrow Donor Program, provides foundational leadership and strategic vision for the organization. This role involves guiding the company's long-term direction and fostering its growth since its inception. Arevalos-Jimenez focuses on establishing and maintaining key relationships with stakeholders, ensuring the organization's mission is consistently advanced. The President & Co-Founder's responsibilities include championing the core values and objectives that underpin the National Marrow Donor Program's life-saving work. By leveraging extensive experience, Chris Arevalos-Jimenez plays a pivotal part in expanding the organization's reach and impact. This executive's commitment is essential to the continued success of facilitating life-saving transplants.

Sydney Salamy, the Chapter President at National Marrow Donor Program, leads regional operational efforts and community engagement initiatives. This position involves overseeing local chapter activities, driving donor recruitment, and raising awareness about the importance of cellular therapy. Salamy ensures that chapter operations align with the broader organizational mission and strategic objectives. The Chapter President's responsibilities include managing local resources and fostering volunteer participation to maximize impact. By directing chapter-specific strategies, Sydney Salamy directly contributes to expanding the donor pool and supporting patients in their region. This executive's focus is on strengthening the National Marrow Donor Program's presence at the community level.

Komal Khoja, the President at National Marrow Donor Program, directs strategic operations and program development to enhance the organization's life-saving capabilities. This leadership role focuses on driving initiatives that expand access to cellular therapies and increase donor participation. Khoja oversees the implementation of innovative strategies aimed at improving patient outcomes and streamlining the transplant process. The President's responsibilities include fostering key partnerships and ensuring operational efficiency across all managed programs. By leading critical initiatives, Komal Khoja significantly contributes to the National Marrow Donor Program's mission. This executive's efforts are vital to advancing the organization's impact in saving lives.

Robert Hanson, the Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer at National Marrow Donor Program, architects and safeguards the organization's technological infrastructure. This multifaceted role encompasses leading all aspects of technology development, information security, and data privacy. Hanson ensures the integrity and security of sensitive patient and donor data, implementing robust cybersecurity measures. The Vice President, Technology & Officer & Dpo Chief Technology Officer & Chief Information Security Officer's responsibilities include driving digital transformation initiatives and enhancing operational efficiency through advanced technological solutions. By managing the technology roadmap, Robert Hanson supports the organization's mission to connect patients with life-saving transplants. This executive's strategic vision ensures the National Marrow Donor Program leverages cutting-edge technology to achieve its goals.

Dennis Confer, the Chief Medical Officer at National Marrow Donor Program, provides critical medical leadership and strategic direction for all clinical operations. This role involves overseeing medical protocols, ensuring the highest standards of patient care, and driving advancements in transplant medicine. Confer guides the organization's approach to medical research and development, focusing on improving transplant success rates and expanding treatment options. The Chief Medical Officer's responsibilities include ensuring compliance with all medical regulations and ethical guidelines. By leading medical innovation, Dennis Confer directly enhances the organization's ability to save lives through cellular therapy. This executive's expertise is vital to the National Marrow Donor Program's mission of facilitating life-saving transplants.